Gout Inflammation and the Molecular Clock
Therapy Area
Allergy & Immunology GOUT inflammation may follow a timed molecular sequence that opens distinct therapeutic windows for phase-specific treatment. A new review proposes that gout inflammation should be understood not as a single inflammatory event, but as a programmed process that unfolds across three distinct phases. Using the Gout Inflammation Time Programming model, the authors describe a continuum that begins with crystal sensing, advances through a decisive adaptation period, and may ultimately progress to chronic tissue damage. The first stage, termed the Perception phase, occurs within the first 24 hours after monosodium urate crystal recognition. During this period, activation of the NLRP3 inflammasome and a neutrophil-driven inflammatory burst are presented as the dominant early drivers of acute gout inflammation. According to the review, this narrow window may be especially important for targeting upstream triggers before the inflammatory cascade becomes more established. The model next moves into an Adaptation phase spanning 24 to 72 hours. Here, the review highlights immunometabolic reprogramming in macrophages and synovial fibroblasts as a key determinant of whether inflammation resolves or progresses. Metabolic disruptions such as succinate accumulation and impaired autophagy are described as potential therapeutic checkpoints during this stage.
Published: April 6, 2026 5:53 pm
Source: European Medical Journal — Read original